Days alive and at home after hip fracture: a cross-sectional validation of a patient-centred outcome measure using routinely collected data.
In: BMJ Quality & Safety, Jg. 32 (2023-09-01), Heft 9, S. 546-556
academicJournal
Zugriff:
Background Days alive and at home (DAH) is a patient centered outcome measureable in routinely collected health data. The validity and minimally important difference (MID) in hip fracture have not been evaluated. Objective We assessed construct and predictive validity and estimated a MID for the patient-centred outcome of DAH after hip fracture admission. Methods This is a cross-sectional observational study using linked health administrative data in Ontario, Canada. DAH was calculated as the number of days alive within 90 days of admission minus the number of days hospitalised or institutionalised. All hospital admissions (2012-2018) for hip fracture in adults aged >50 years were included. Construct validity analyses used Bayesian quantile regression to estimate the associations of postulated patient, admission and process-related variables with DAH. The predictive validity assessed was the correlation of DAH in 90 days with the value from 91 to 365 days; and the association and discrimination of DAH in 90 days predicting subsequent mortality. MID was estimated by averaging distribution-based and clinical anchor-based estimates. Results We identified 63 778 patients with hip fracture. The median number of DAH was 43 (range 0-87). In the 90 days after admission, 8050 (12.6%) people died; a further 6366 (10.0%) died from days 91 to 365. Associations between patient-level and admission-level factors with the median DAH (lower with greater age, frailty and comorbidity, lower if admitted to intensive care or having had a complication) supported construct validity. DAH in 90 days after admission was strongly correlated with DAH in 365 days after admission (r=0.922). An 11-day MID was estimated. Conclusion DAH has face, construct and predictive validity as a patient-centred outcome in patients with hip fracture, with an estimated MID of 11 days. Future research is required to include direct patient perspectives in confirming MID. [ABSTRACT FROM AUTHOR]
Copyright of BMJ Quality & Safety is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Days alive and at home after hip fracture: a cross-sectional validation of a patient-centred outcome measure using routinely collected data.
|
---|---|
Autor/in / Beteiligte Person: | McIsaac, Daniel I. ; Talarico, Robert ; Jerath, Angela ; Wijeysundera, Duminda N. |
Zeitschrift: | BMJ Quality & Safety, Jg. 32 (2023-09-01), Heft 9, S. 546-556 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 2044-5415 (print) |
DOI: | 10.1136/bmjqs-2021-013150 |
Schlagwort: |
|
Sonstiges: |
|